skip to main content
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

もっと見る

Resources

もっと見る

Products

もっと見る

もっと見る

99+ Total results for product and free and sample content found

世界の薬事規制動向&情報を配信

What Breast Cancer Drug Developers Need to Know Now About Regulatory Policies

21 Oct 2022

Breast_cancer_Awareness

As biopharma continues to make progress developing novel and more targeted cancer therapies, regulators are responding with innovative and collaborative approaches to reviewing cancer products, aiming to resolve questions earlier and review products more quickly. Pink Sheet closely covers these programs, helping readers understand the expectations, challenges and opportunities, as well as lessons from companies putting policy into practice. This ebook takes some of our recent articles on special review mechanisms and regulators’ data expectations.

Topic Clinical Trial Optimization

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

Outlook 2022: What Next for Pharma After a Year of Innovation and Growth?

02 Mar 2022

Outlook 2022: What Next for Pharma After a Year of Innovation and Growth?

Look ahead with our Pharma Outlook 2022 Extract as we discuss what's coming up in the biopharma space.

Biomedtracker: 開発中医薬品をFDA承認確率で評価, Meddevicetr...

Don’t miss your free extract of Early 2022 Outlook Report

08 Feb 2022

Don’t miss your free extract of Early 2022 Outlook Report

In pharma’s fast paced and continually evolving world, accurately anticipating the impact of events on the horizon is critical to your success.

Topic Business Strategies

Pharma Intelligence Apps

Not all news services are created equal

04 Jan 2022

Not all news services are created equal

Pharma Insights team of trusted journalists bring you the most critical news and analysis round the clock. Our global team of journalists and editors use their extensive experience and relationships with regulators, associations, and industry leaders to bring you in-depth insights so you can stay current on the latest market developments. Register for your free trial today to find out what our editors and journalists are reporting on now.

Not all biopharma IPOs are created equal.

18 Nov 2021

Not all biopharma IPOs are created equal.

Scrip's team of trusted industry experts bring you the mos critical news and analysis on key commercial topics, from licensing to clinical trials, and competitor activity, around the clock. Our global team of journalists and editors use their extensive experience and relationships with regulators, associations, and industry leaders to bring you in-depth insights so you can stay current on the latest market developments. Register for your free trial today to find out what our editors and journalists are reporting on now.

Pharma Intelligence Apps

Not all generics firms are created equal

18 Nov 2021

Not all generics firms are created equal

Get unrivalled coverage, news, and analysis of the global generics, biosimilars, and value-added medicines industries from the industry experts at Generics Bulletin. Our global team of journalists and editors use their extensive experience and relationships with regulators, associations, and industry leaders to bring you in-depth insights so you can stay current on the latest market developments. Register for your free trial today to find out what our editors and journalists are reporting on now.

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。


新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。

お問合せの際はフォームまたは下記メールアドレスをご利用頂くか、営業担当者の携帯電話までご連絡下さいますようご協力をお願い申し上げます。

インフォーマインテリジェンス合同会社
サイトライン(旧ファーマインテリジェンス)
Eメール:
inquiry.jp@informa.com


オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。